Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc. scores highest on Nitro (73) and lowest on Price (0). Its PosiPenta is 33.50 out of 100, weaker than most similar companies.
On the Penta Grid this week, Lifecore Biomedical, Inc. is Grid #704 of 837 in the Healthcare sector in United States, and Grid #3,403 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Lifecore Biomedical, Inc. | 33.50 | 0 | 46 | 73 | 2 | 46 |
| American Well Corporation | 54.33 | 40 | 40 | 85 | 67 | 39 |
| Monogram Technologies Inc. | 50.30 | 2 | 45 | 94 | 38 | 72 |
| Utah Medical Products, Inc. | 79.49 | 58 | 90 | 95 | 82 | 72 |
| Vanda Pharmaceuticals Inc. | 41.72 | 38 | 48 | 24 | 43 | 55 |
| Lexeo Therapeutics, Inc. | 36.08 | 40 | 31 | 19 | 58 | 32 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -5.02 |
| P/B ratio | -7.09 |
EEarnings
| Trailing EPS | ₹-120.29 |
| Forward EPS | ₹-73.88 |
NNitro
| Price | 604.28 |
| 52-week high | 850.54 |
| 52-week low | 343.82 |
| Fall from 52-week high | 29.0% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 9.72 |
AAnchor
| Beta (price swings) | 0.98 |
| Market cap | ₹2,290 Cr |
| Insider holding | 3.04% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Lifecore Biomedical, Inc.'s PosiPenta score?
Lifecore Biomedical, Inc.'s PosiPenta is 33.50 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Lifecore Biomedical, Inc. stand on the Penta Grid?
On the Penta Grid this week, Lifecore Biomedical, Inc. is Grid #704 of 837 in the Healthcare sector in United States, and Grid #3,403 of 4,000 in United States.
Which PosiPenta pillar is strongest for Lifecore Biomedical, Inc.?
Nitro (momentum), with a score of 73 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Lifecore Biomedical, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Lifecore Biomedical, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.53 points, from 30.97 to 33.50.
PositoAI is for research and education only and is not investment advice.